School of Medicine


Showing 11-20 of 47 Results

  • Michele Barry, MD, FACP

    Michele Barry, MD, FACP

    Drs. Ben & A. Jess Shenson Professor, Senior Associate Dean, Global Health, Director, Center for Innovation in Global Health, Professor of Medicine & Senior Fellow at the Woods Institute and at the Freeman Spogli Institute

    Current Research and Scholarly Interests Areas of research
    Ethical Aspects of research conducted overseas
    Clinical Tropical Diseases
    Globalization's Impact upon Health Disparities
    Hemorrhagic Viruses

  • Fiona Barwick

    Fiona Barwick

    Clinical Associate Professor, Psychiatry and Behavioral Sciences - Stanford Center for Sleep Sciences and Medicine

    Current Research and Scholarly Interests Research interests focus on expanding sleep education, improving sleep health, optimizing treatment for circadian rhythm disorders, and adapting treatment for insomnia in populations where developmental, medical, psychiatric and cultural factors intersect.

    Current research projects include developing and piloting integrated protocols for treating sleep problems that co-occur with medical conditions such as chronic pain or POTS. Ongoing collaborations include delivery of a CBTI protocol in Mandarin via telehealth to patients at Chongqing Traditional Chinese Medicine Hospital in China. Past projects include investigation of the link between RLS and the gut microbiome and a survey of student sleep health.

  • Nataly Sumarriva Beck

    Nataly Sumarriva Beck

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    Current Research and Scholarly Interests Dr. Beck's clinical research includes the relationship between catatonia and substance use. In addition, she works on first-episode psychosis, with a focus on treatments in the young adult population.

  • Catherine Benedict

    Catherine Benedict

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    Current Research and Scholarly Interests My research focuses on improving cancer survivorship through better understanding of long-term health outcomes and through the development of theoretically driven, evidence-based behavioral interventions to improve adjustment, risk management, and quality of life. To this end, I lead studies aimed to guide and support patient decision-making and self-management after cancer. Much of my work focuses on the experiences of young adults affected by cancer.

  • Ori-Michael Johanan Benhamou

    Ori-Michael Johanan Benhamou

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    Bio Dr. Benhamou received his Bachelor's degree at Duke University and went on to complete medical school at Ben-Gurion University. He completed his residency in Psychiatry at Westchester Medical Center and fellowship in Addiction Medicine at Stanford. He has published works in the areas of suicide, autoimmune encephalitis and addiction. His current interests include substance abuse, the role of transcranial magnetic stimulation on addiction and the intersection of suicide and substance abuse.

  • Brandon S. Bentzley, MD, PhD

    Brandon S. Bentzley, MD, PhD

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    Bio Dr. Bentzley is a psychiatrist and Instructor in the Department of Psychiatry & Behavioral Sciences at Stanford University School of Medicine.

    His clinical interests include the treatment of substance use disorders and depression using advanced techniques and technologies such as neurostimulation. His research interests include advances in neurostimulation-based treatments, suicide prevention and neuroeconomics.

    As a postdoctoral fellow, Dr. Bentzley was the recipient of a National Institute of Mental Health research training grant. Currently, he is principal investigator on a study funded by the National Institute on Drug Abuse that focuses on understanding the role of dopamine in economic decision making. Further, Dr. Bentzley is co-investigator of a study that received grant support from the American Foundation for Suicide Prevention. This randomized, controlled trial investigates ketamine therapy with a transition to buprenorphine for the treatment of acute suicidality. The study is scheduled for completion in 2022.

    Dr. Bentzley is also a consultant for industry innovators, such as an organization conducting research into new treatments for opioid use disorder and another focusing on data science and psychometrics.

    He has authored articles on surgically implanted neuromodulatory technology for treatment-resistant depression, the origins of selective vulnerability to opioid addiction, the antidepressant effects of ketamine, the role of neurons in cocaine demand, and other topics.

    His work has appeared in the American Journal of Psychiatry, Proceedings of the National Academy of Sciences, Molecular Psychiatry, and elsewhere. In addition, he is a reviewer for the Journal of Substance Abuse Treatment, European Journal of Neuroscience, Behavioural Brain Research, and Addiction Biology.

    Dr. Bentzley has delivered invited lectures including psychiatry grand grounds at Stanford and other medical centers. He has held leadership positions on committees focused on medical education and residency programs, among them Stanford?s Psychiatry Residency Neuroscience Curriculum Committee and the Psychiatry Residency Wellbeing Committee.

    Dr. Bentzley has received honors for his scholarship. He was a member of a team that won the American Psychiatric Association?s ?MindGames? national residency competition, was a Ruth Fox Scholar, as designated by the American Society of Addiction Medicine, and won the Distinguished Graduate of the Year Award from the Medical University of South Carolina.

    He is a member of the American Psychiatric Association, American Society of Addiction Medicine, American Society for Neurosciences, and American Association for the Advancement of Science. Dr. Bentzley has provided community outreach mental health services as a clinical volunteer.

  • Michele Berk

    Michele Berk

    Assistant Professor of Psychiatry and Behavior Sciences (Child and Adolescent Psychiatry and Child Development) at the Stanford University Medical Center

    Current Research and Scholarly Interests The focus of my research is on adolescent suicidal and self-harm behavior. I am currently one of four Principal Investigators of a multisite NIMH-sponsored RCT of DBT for adolescents at high risk for suicide (NCT01528020: Collaborative Adolescent Research on Emotions and Suicide [CARES], PI: Linehan, McCauley, Berk, & Asarnow) aimed at evaluating the efficacy of DBT with adolescents compared to a combined individual and group supportive therapy control condition (IGST).

Footer Links:

Stanford Medicine Resources: